(Q45223757)

11 December 2017

Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts (English)

1 reference

11 December 2017

Douglas L Mann

8

0 references

author name string

Joshua D Lovelock

1

1 reference

11 December 2017

Andrew H Baker

2

1 reference

11 December 2017

Feng Gao

3

1 reference

11 December 2017

Jing-Fei Dong

4

1 reference

11 December 2017

Angela L Bergeron

5

1 reference

11 December 2017

Willie McPheat

6

1 reference

11 December 2017

Natarajan Sivasubramanian

7

1 reference

11 December 2017

1 February 2005

1 reference

American Journal of Physiology Heart and Circulatory Physiology

11 December 2017

1 reference

11 December 2017

288

1 reference

11 December 2017

2

1 reference

11 December 2017

H461-8

1 reference

Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3.

11 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

The deletion of transforming growth factor-beta-induced myofibroblasts depends on growth conditions and actin organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: characterization of their infection into rabbit smooth muscle cells and human MCF-7 a

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Cytokines in kidney disease: the role of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Complex roles of tissue inhibitors of metalloproteinases in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Myofibroblasts differentiate from fibroblasts when plated at low density

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Matrix metalloproteinases: regulation and dysregulation in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter. Specific lack of expression in neoplastic JB6 cells may reflect altered gene methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Apoptosis of wound fibroblasts induced by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

Stimulatory effect of endogenous tissue inhibitor of metalloproteinases-1 (TIMP-1) overexpression on type IV collagen and laminin gene expression in rat mammary carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00402.2004

10.1152/AJPHEART.00402.2004

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference